<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04936581</url>
  </required_header>
  <id_info>
    <org_study_id>205/15</org_study_id>
    <nct_id>NCT04936581</nct_id>
  </id_info>
  <brief_title>Patient Reported Outcomes Following Cancer of the Rectum</brief_title>
  <acronym>PROCaRe</acronym>
  <official_title>Patient Reported Outcomes Following Cancer of the Rectum</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Gregorio Marañón</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Navarrra Hospital (Clinica Universitaria)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital de Leon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital del Río Hortega</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Gregorio Marañón</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The surgical management of rectal cancer includes a Total Mesorectal Excison (TME); depending&#xD;
      on the height of the tumor, the problem of preservation of the anal sphincter arises, being&#xD;
      able to perform a low anterior resection, an ultra-low anterior resection (RAUB) or an&#xD;
      intersphincteric dissection. In some cases invading the sphincters or the puborectalis&#xD;
      muscle, an abdominoperineal resection needs to be performed, being the gold standard in this&#xD;
      particular situation so far.&#xD;
&#xD;
      TME can be performed by open, laparoscopic, robotic or transanal approaches, as long as the&#xD;
      oncological principles for the resection are achieved. Unfortunately, up to 90% of these&#xD;
      patients will present a change in bowel habit, ranging from an increased frequency of bowel&#xD;
      movements to the degree of fecal incontinence or evacuation dysfunction. Of these patients,&#xD;
      25-50% will have a severe alteration in the quality of life. This wide spectrum of symptoms&#xD;
      has been called &quot;low anterior resection syndrome&quot; (LARS). Other collateral damage is the&#xD;
      change in sexual and urinary function, due to hypogastric plexus injury. There is a&#xD;
      significant lack of multicenter prospective studies that provide evidence, and that reveal&#xD;
      the functional results and quality of life of these techniques available to date for the&#xD;
      management of rectal cancer.&#xD;
&#xD;
      The study is set up as a prospective multicentre observational study. Inclusion criteria are:&#xD;
      1) patients over 18 years old, 2) diagnosed with rectal cancer located below the peritoneal&#xD;
      reflection, defined by preoperative MRI, 3) undergoing Open, laparoscopic, robotic or&#xD;
      Transanal Total Mesorectal Excision (taTME) approaches, 4) with/without derivative stoma and&#xD;
      5) with/without neoadjuvant treatment. Exclusion criteria are: 1) Upper rectal cancer,&#xD;
      located above the peritoneal reflection, 2) previous radical prostatectomy, 3) previous&#xD;
      pelvic radiotherapy, 4) rectal resection without primary anastomosis, 5) intraoperative&#xD;
      findings of peritoneal carcinomatosis, 6) stage IV disease, 7) multivisceral or en-bloc&#xD;
      resection, which includes uterus, prostate, vagina or bladder, 8) rectal resection due to a&#xD;
      benign condition, 9) rectal resection due to a recurrence of rectal cancer (previous anterior&#xD;
      resection or another primary neoplasm), 10) rectal resection following a 'watch &amp; wait'&#xD;
      program, 11) emergency surgery, 12) previous derivative colostomy 13) inflammatory bowel&#xD;
      disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Accepting an alpha risk of 0.05 and a beta risk of 0.2 in a two-sided test, 45 subjects are&#xD;
      necessary in first group and 45 in the second to recognize as statistically significant a&#xD;
      difference greater than or equal to 2 units. The common standard deviation is assumed to be&#xD;
      3. It has been anticipated a drop-out rate of 20% Primary outcomes are LARS and Vaizey score.&#xD;
      Secondary outcomes included are QLQ C30 and CR29, sexual function questionnaire&#xD;
      (female/male), urinary function questionnaire and postoperative complications (Clavien-Dindo&#xD;
      classification) Data will be collected in an online secure and protected repository (Castor&#xD;
      edc). The planned study period is 2 years (September 2021 - September 2023).&#xD;
&#xD;
      It is essential to have a validated instrument that allows us to assess sphincter function&#xD;
      and the different aspects of quality of life in operated patients, since increased survival&#xD;
      in this pathology has led to greater importance in the evaluation functional outcome and&#xD;
      quality of life; Furthermore, there are recent studies that speak of the direct relationship&#xD;
      between these factors.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">September 2023</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Low anterior resection syndrome (LARS) score</measure>
    <time_frame>2022</time_frame>
    <description>LARS score from 0-42 where 0 means better outcomes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vaizey score</measure>
    <time_frame>2022</time_frame>
    <description>Incontinence score from 0-28 where 0 means better outcomes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>QLQ C30</measure>
    <time_frame>2022</time_frame>
    <description>Quality of Life questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QLQ CR29</measure>
    <time_frame>2022</time_frame>
    <description>Quality of life questionnaire, colorectal cancer related</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Male sexual function</measure>
    <time_frame>2022</time_frame>
    <description>IIEF questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Female sexual function</measure>
    <time_frame>2022</time_frame>
    <description>FSFI questionnaires</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary function</measure>
    <time_frame>2022</time_frame>
    <description>IPSS questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>2022</time_frame>
    <description>Dindo-Clavien classification</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Sphincter Ani Incontinence</condition>
  <condition>Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>Open Total Mesorectal Excision</arm_group_label>
    <description>Patients undergoing open low anterior resection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laparoscopic Total Mesorectal Excision</arm_group_label>
    <description>Patients undergoing laparoscopic low anterior resection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Robotic Total Mesorectal Excision</arm_group_label>
    <description>Patients undergoing robotic low anterior resection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transanal Total Mesorectal Excision</arm_group_label>
    <description>Patients undergoing transanal Total Mesorectal Excision (taTME)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open Total Mesorectal Excision</intervention_name>
    <description>Open approach for Total Mesorectal Excision</description>
    <arm_group_label>Open Total Mesorectal Excision</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic Total Mesorectal Excision</intervention_name>
    <description>Laparoscopic approach for Total Mesorectal Excision</description>
    <arm_group_label>Laparoscopic Total Mesorectal Excision</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Robotic Total Mesorectal Excision</intervention_name>
    <description>Robotic approach for Total Mesorectal Excision</description>
    <arm_group_label>Robotic Total Mesorectal Excision</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transanal Total Mesorectal Excision</intervention_name>
    <description>Transanal approach for Total Mesorectal Excision</description>
    <arm_group_label>Transanal Total Mesorectal Excision</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants that meet the criteria will be identified in each centre&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients over 18 years old&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
          -  Diagnosed with rectal cancer located below the peritoneal reflection, defined by&#xD;
             preoperative MRI&#xD;
&#xD;
          -  Open, laparoscopic, robotic or Transanal Total Mesorectal Excision (taTME) approaches&#xD;
&#xD;
          -  Patients with/without derivative stoma&#xD;
&#xD;
          -  Patients with/without neoadjuvant treatment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Upper rectal cancer, located above the peritoneal reflection&#xD;
&#xD;
          -  Previous radical prostatectomy&#xD;
&#xD;
          -  Previous pelvic radiotherapy&#xD;
&#xD;
          -  Rectal resection without primary anastomosis&#xD;
&#xD;
          -  Intraoperative findings of peritoneal carcinomatosis&#xD;
&#xD;
          -  Stage IV disease&#xD;
&#xD;
          -  Multivisceral or en-bloc resection, which includes uterus, prostate, vagina or bladder&#xD;
&#xD;
          -  Rectal resection due to a benign condition&#xD;
&#xD;
          -  Rectal resection due to a recurrence of rectal cancer (previous anterior resection or&#xD;
             another primary neoplasm)&#xD;
&#xD;
          -  Rectal resection following a 'watch &amp; wait' program&#xD;
&#xD;
          -  Emergency surgery&#xD;
&#xD;
          -  Previous derivative colostomy&#xD;
&#xD;
          -  Inflammatory bowel disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Patricia Tejedor</last_name>
    <phone>+34 91 586 7007</phone>
    <email>patricia.tejedor@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Patricia Tejedor</last_name>
    <phone>+34 91 586 7007</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Gregorio Marañón</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <results_reference>
    <citation>Bonjer HJ, Deijen CL, Abis GA, Cuesta MA, van der Pas MH, de Lange-de Klerk ES, Lacy AM, Bemelman WA, Andersson J, Angenete E, Rosenberg J, Fuerst A, Haglind E; COLOR II Study Group. A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med. 2015 Apr 2;372(14):1324-32. doi: 10.1056/NEJMoa1414882.</citation>
    <PMID>25830422</PMID>
  </results_reference>
  <results_reference>
    <citation>Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM, Heath RM, Brown JM; MRC CLASICC trial group. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet. 2005 May 14-20;365(9472):1718-26.</citation>
    <PMID>15894098</PMID>
  </results_reference>
  <results_reference>
    <citation>2017 European Society of Coloproctology (ESCP) collaborating group. An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME). Colorectal Dis. 2018 Sep;20 Suppl 6:33-46. doi: 10.1111/codi.14376.</citation>
    <PMID>30255642</PMID>
  </results_reference>
  <results_reference>
    <citation>Kim JY, Kim NK, Lee KY, Hur H, Min BS, Kim JH. A comparative study of voiding and sexual function after total mesorectal excision with autonomic nerve preservation for rectal cancer: laparoscopic versus robotic surgery. Ann Surg Oncol. 2012 Aug;19(8):2485-93. doi: 10.1245/s10434-012-2262-1. Epub 2012 Mar 21.</citation>
    <PMID>22434245</PMID>
  </results_reference>
  <results_reference>
    <citation>Park SY, Choi GS, Park JS, Kim HJ, Ryuk JP, Yun SH. Urinary and erectile function in men after total mesorectal excision by laparoscopic or robot-assisted methods for the treatment of rectal cancer: a case-matched comparison. World J Surg. 2014 Jul;38(7):1834-42. doi: 10.1007/s00268-013-2419-5.</citation>
    <PMID>24366278</PMID>
  </results_reference>
  <results_reference>
    <citation>Kim HJ, Choi GS, Park JS, Park SY, Yang CS, Lee HJ. The impact of robotic surgery on quality of life, urinary and sexual function following total mesorectal excision for rectal cancer: a propensity score-matched analysis with laparoscopic surgery. Colorectal Dis. 2018 May;20(5):O103-O113. doi: 10.1111/codi.14051.</citation>
    <PMID>29460997</PMID>
  </results_reference>
  <results_reference>
    <citation>Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J, Quirke P, West N, Rautio T, Thomassen N, Tilney H, Gudgeon M, Bianchi PP, Edlin R, Hulme C, Brown J. Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer: The ROLARR Randomized Clinical Trial. JAMA. 2017 Oct 24;318(16):1569-1580. doi: 10.1001/jama.2017.7219.</citation>
    <PMID>29067426</PMID>
  </results_reference>
  <results_reference>
    <citation>Andolfi C, Umanskiy K. Appraisal and Current Considerations of Robotics in Colon and Rectal Surgery. J Laparoendosc Adv Surg Tech A. 2019 Feb;29(2):152-158. doi: 10.1089/lap.2018.0571. Epub 2018 Oct 16. Review.</citation>
    <PMID>30325690</PMID>
  </results_reference>
  <results_reference>
    <citation>Sylla P, Rattner DW, Delgado S, Lacy AM. NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc. 2010 May;24(5):1205-10. doi: 10.1007/s00464-010-0965-6. Epub 2010 Feb 26.</citation>
    <PMID>20186432</PMID>
  </results_reference>
  <results_reference>
    <citation>Burch J, Taylor C, Wilson A, Norton C. Symptoms affecting quality of life after sphincter-saving rectal cancer surgery: A systematic review. Eur J Oncol Nurs. 2021 Jun;52:101934. doi: 10.1016/j.ejon.2021.101934. Epub 2021 Mar 22.</citation>
    <PMID>33845303</PMID>
  </results_reference>
  <results_reference>
    <citation>Christensen P, Im Baeten C, Espín-Basany E, Martellucci J, Nugent KP, Zerbib F, Pellino G, Rosen H; MANUEL Project Working Group. Management guidelines for low anterior resection syndrome - the MANUEL project. Colorectal Dis. 2021 Feb;23(2):461-475. doi: 10.1111/codi.15517. Epub 2021 Jan 24.</citation>
    <PMID>33411977</PMID>
  </results_reference>
  <results_reference>
    <citation>Li K, He X, Tong S, Zheng Y. Risk factors for sexual dysfunction after rectal cancer surgery in 948 consecutive patients: A prospective cohort study. Eur J Surg Oncol. 2021 Aug;47(8):2087-2092. doi: 10.1016/j.ejso.2021.03.251. Epub 2021 Mar 29.</citation>
    <PMID>33832775</PMID>
  </results_reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 9, 2021</study_first_submitted>
  <study_first_submitted_qc>June 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2021</study_first_posted>
  <last_update_submitted>June 27, 2021</last_update_submitted>
  <last_update_submitted_qc>June 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Gregorio Marañón</investigator_affiliation>
    <investigator_full_name>Patricia Tejedor</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>rectal cancer</keyword>
  <keyword>taTME</keyword>
  <keyword>laparoscopic TME</keyword>
  <keyword>robotic TME</keyword>
  <keyword>open TME</keyword>
  <keyword>low anterior resection syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

